The FDA, CDC and CMS want to speed access to diagnostic tools during public health emergencies, such as an infectious disease outbreak.
The FDA will authorize emergency use of tests, the CDC will provide lab and epidemiology expertise, and CMS will ensure that labs produce accurate and timely results.
Before an emergency, the task force will identify gaps in protocols by reviewing recent emergency response experiences and current practices.
The task force will meet twice yearly.
More articles on clinical leadership and infection control:
WHO issues urgent call for more Ebola funding
State-mandated reporting laws may lower time spent on infection control activities, survey finds
SHEA names permanent executive director
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.